Campbell & Co Investment Adviser’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,443
| Closed | -$1.57M | – | 1149 |
|
|
2025
Q1 | $1.57M | Buy |
+6,443
| New | +$1.57M | 0.12% | 265 |
|
|
2024
Q1 | – | Sell |
-8,080
| Closed | -$2.61M | – | 1113 |
|
|
2023
Q4 | $2.61M | Buy |
+8,080
| New | +$2.61M | 0.24% | 75 |
|
|
2023
Q3 | – | Sell |
-1,317
| Closed | -$499K | – | 951 |
|
|
2023
Q2 | $499K | Buy |
+1,317
| New | +$499K | 0.09% | 438 |
|
|
2022
Q3 | – | Sell |
-1,167
| Closed | -$578K | – | 712 |
|
|
2022
Q2 | $578K | Buy |
1,167
+502
| +75% | +$249K | 0.16% | 227 |
|
|
2022
Q1 | $375K | Buy |
+665
| New | +$375K | 0.1% | 385 |
|
|
2021
Q4 | – | Sell |
-350
| Closed | -$261K | – | 625 |
|
|
2021
Q3 | $261K | Sell |
350
-450
| -56% | -$336K | 0.09% | 418 |
|
|
2021
Q2 | $515K | Buy |
+800
| New | +$515K | 0.21% | 150 |
|
|
2020
Q1 | – | Sell |
-1,249
| Closed | -$462K | – | 71 |
|
|
2019
Q4 | $462K | Buy |
+1,249
| New | +$462K | 0.14% | 257 |
|
|
2014
Q3 | – | Sell |
-4,821
| Closed | -$577K | – | 194 |
|
|
2014
Q2 | $577K | Buy |
+4,821
| New | +$577K | 0.23% | 117 |
|
|
2013
Q4 | – | Sell |
-1,745
| Closed | -$205K | – | 219 |
|
|
2013
Q3 | $205K | Sell |
1,745
-2,621
| -60% | -$308K | 0.04% | 221 |
|
|
2013
Q2 | $490K | Buy |
+4,366
| New | +$490K | 0.09% | 211 |
|